搜尋結果
Neurocrine Biosciences' Huntington's disease drug gets FDA approval (April 30)
Reuters· 9 小時前, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on ...
For Japan Inc, the weak yen may be too much of a good thing
Reuters· 10 小時前Corporate Japan is starting to wonder if the weak yen has become too much of a good thing. The ...
Chipmaker Wolfspeed forecasts quarterly revenue below estimates as EV sales growth slows
Reuters· 12 小時前Chipmaker Wolfspeed forecast current-quarter revenue below estimates on Wednesday as automakers ...
PTC forecasts quarterly revenue below estimates
Reuters· 12 小時前Industrial software maker PTC forecast quarterly revenue below estimates while also slightly tightening full year guidance ...
Thirty years on, fans pay tribute to Senna at Imola
Reuters· 16 小時前Motor racing fans and politicians gathered at Italy's Imola circuit on Wednesday to pay ...
Jakarta show sees Chinese EVs gaining stronger ground in Indonesian market
China Daily· 20 小時前Chinese electric vehicles are gaining a stronger foothold in the Indonesian market as Southeast Asia's largest economy is ...
To train car dealers on EVs and other topics, Ford turns to gamification and AI-powered education
CNBC· 23 小時前Ford Motor is launching a new training program for more than 3,000 U.S. franchised dealers on ...
Newey confirms 2025 exit in blow to Red Bull
Reuters· 23 小時前Newey will leave Red Bull in the first quarter of 2025, after 19 years at the F1 team, Red Bull ...
KPS Is Said to Lead Bidding for €3 Billion Siemens Motors Unit
Bloomberg· 24 小時前Have a confidential tip for our reporters? KPS Capital Partners is emerging as the frontrunner to acquire Siemens AG’s Innomotics ...
Will GM Regret Kicking Apple CarPlay off the Dashboard?
Bloomberg· 1 日前The uneasy relationship between Detroit and Cupertino is on display in a flawed rollout of GM’s ...